14:00-14:45

MEDICAL GRADE CANNABIS: DEFINITIONS AND CONCEPTS

14:00-14:25
Dr. Raquel Peyraube
Executive Committee, the International Association for Cannabinoid Medicines, Uruguay

14:25-14:40
Live Discussion/Q&A

14:45-15:45

CULTIVATING SCIENCE IN THE MEDICAL CANNABIS BUSINESS

14:45-15:00
EMERGING TECHNOLOGIES FOR TESTING AND ANALYZING MEDICAL CANNABIS COMPOUNDS
Joshua Alper
Chief Strategy Officer, Harvest 360 Technologies, USA

15:00-15:05 – Live Q&A with Joshua Alper

15:05-15:20
TLE: CHANGING THE PERCEPTION OF PLANT-BASED MEDICINE BY USING SCIENCE WITH GREENWAY DNA
Clare Navas
CEO & Founder, The Leaf Extract, Spain

15:20-15:25 Live Q&A with Clare Navas

15:25-15:40
SAVE THE TERPS, ORG CANNABIS FLOWER QUALITY SCORING SYSTEM WITH RESPECT TO TERPENOID CONTENT AND WATER ACTIVITY
Andrew Samann
CEO, Orion GMP Solutions, USA

15:40-15:45 Live Q&A with Andrew Samann

16:30-17:30

PANEL DISCUSSION: WOMEN IN THE FOREFRONT OF CANNABIS INNOVATION

16:30-17:20

Moderator:

Mrs. Ma’ayan Weisberg Joels
CEO, Hiliz, Israel

Panelists:

Mrs. Ma’ayan Weisberg Joels
CEO, Hiliz, Israel

Mrs. Iris Bincovich
CEO, InnoCan Pharma, Israel

Mrs. Yona Cymerman
Co-Founder and COO, Can Innovations, Israel

17:20-17:30
Live Discussion/Q&A

13:45-14:20

MEET THE EXPERTS: CANNABIS PLANT SCIENCE: INTERPLAY BETWEEN CANNABINOIDS AND ENVIRONMENTAL CONDITIONS

13:45-14:10
Dr. Nirit Bernstein
Ph.D., Senior Research Scientist, ARO, Volcani Institute, Israel

14:10-14:20
Live Discussion/Q&A

ABSTRACT PRESENTATIONS I

14:20-14:30
A PILOT RANDOMISED PLACEBO-CONTROLLED TRIAL OF CANNABIDIOL TO REDUCE SEVERE BEHAVIOURAL PROBLEMS IN CHILDREN AND ADOLESCENTS WITH INTELLECTUAL DISABILITY
Asst. Prof. Daryl Efron, Australia

14:30-14:40
CANNABIS GENE VARIATION – COMPARISON OF MULTIPLE GENOME ASSEMBLIES
Dr. Oori Weisshaus, Israel

14:40-14:50
TREATING HIDRADENITIS SUPPURATIVA (HS) WITH CANNABIS
Mrs. Irit Avisar, Israel

14:50-15:00
CANNABINOIDS AND CBD FOR BEAUTY AND SKIN DISORDERS
Dr. Jeanette Jacknin, United States

15:00-15:10
CAUSE OR EFFECT: INCREASED PREVALENCE OF CANNABIS USE IN INFLAMMATORY BOWEL DISEASE SYSTEMATIC REVIEW OF THE EPIDEMIOLOGICAL EVIDENCE
Dr. Gabor Z. Xantus, United Kingdom

15:10-15:20
CANNABIS MODULATION OF INFLAMMATORY SKIN DISEASES
Dr. Yehuda Baruch, Israel

15:20-15:30
CANNABIDIOL IN ACUTE LOW BACK PAIN – A PROTOCOL AND RATIONALE OF A CLINICAL EFFECTIVENESS TRIAL
Asst. Prof., Anna Gyarmathy, United Kingdom

ABSTRACT PRESENTATIONS II

14:20-14:30
NOVEL DEVICE AND FORMULATION FOR CANNABIS INHALER
Dr. Eran Toledo, Israel

14:30-14:40
INVESTMENTS IN STRATEGY AND DATA ARE THE KEY TO SUCCESS IN EUROPEAN MEDICAL CANNABIS
Mr. TJ Unger

14:40-14:50
NOVEL DELIVERY PLATFORMS FOR CANNABIS-BASED THERAPIES
Dr. Oren Levy

14:50-15:00
THE MECHANISM OF ACTION AND MOLECULAR TARGET OF CANNABIDIOL IN HUMAN GLIOMA
Dr. Chao Yan

15:00-15:10
CANNABIS AND ITS MEDICALLY RELEVANT EFFECTS: AN ONLINE GENOMIC STUDY DESIGN
Dr. Nancy Saccone

15:10-15:20
MEDICAL CANNABIS AS A THERAPEUTIC RESOURCE: PRELIMINARY STUDY
Dr. Mariano Velazquez

15:20-15:30
TBA

15:30-16:30

THE INTERPLAY OF SCIENCE, BUSINESS AND LAW

14:00-14:15
BUSINESS OPPORTUNITIES WITH NEW REGULATIONS IN LATIN AMERICA: THE BRAZILIAN CASE
Alessandra Mourao
Founder, Nascimento e Mourão Advogados, Brazil

14:15-14:20 – Live Q&A with Alessandra Mourao

14:20-14:35
ENGINEERING AND PATENTING LEGAL CANNABIS
Dr. Joseph Mogan
President, Kotzker Consulting, Llc, USA

14:35-14:40 – Live Q&A with Joseph Mogan

14:40-15:00
THE ROAD TO GAP AND GMP ACCREDITATION – PRACTICAL LESSONS LEARNT, AND THE CHALLENGES OF OPERATING FROM A REMOTE LOCATION
Francois Ferreira
CEO, MG Health, Lesotho

14:55 – 15:00 – Live Q&A with Francois Ferreira

17:00-17:45

WORKSHOP: CANNABIS EXTRACTION AND PURIFICATION METHODS: YOU NEED TO FOCUS IN COMPLIANCE AND THE FINAL PRODUCT REQUIRED

17:00-17:35
Dr. Xavier Nadal
Ph.D., Director, EthnoPhytoTech Research & Consulting, Spain

17:35-17:45
Live Discussion/Q&A

17:45-18:45

INTEGRATING SCIENCE AND BUSINESS: A BRAZILIAN PERSPECTIVE

16:45-17:15
AN OVERVIEW ON CANNABINOID MEDICINE
Dr. David Bearman
MD, University of Wisconsin and University of Washington School of Medicine, USA

17:15-17:35
CONTRIBUTIONS OF CANNABIS COMPANIES TO SCIENCE AND MEDICAL EDUCATION IN BRAZIL
Mr. Gabriel Barbosa
MSc in Biotechnology, R&D and Regulatory Supervisor, HempMeds, Brazil

17:35-17:45
Live Discussion/Q&A

Chair: Mrs. Caroline Heinz
Co-CEO, HempMeds, Brazil